Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Buy
21,217
+9,795
+86% +$395K ﹤0.01% 3012
2026
Q1
$378K Buy
+11,422
New +$371K ﹤0.01% 3284
2025
Q2
Sell
-23,917
Closed -$442K 3299
2025
Q1
$442K Buy
23,917
+7,453
+45% +$134K ﹤0.01% 2491
2024
Q4
$271K Buy
+16,464
New +$233K ﹤0.01% 2540
2023
Q4
Sell
-42,569
Closed -$213K 2333
2023
Q3
$213K Sell
42,569
-674
-2% -$4.67K ﹤0.01% 2122
2023
Q2
$395K Sell
43,243
-35,929
-45% -$335K ﹤0.01% 1850
2023
Q1
$748K Buy
79,172
+43,043
+119% +$394K ﹤0.01% 1638
2022
Q4
$361K Sell
36,129
-25,305
-41% -$281K ﹤0.01% 1921
2022
Q3
$732K Buy
+61,434
New +$614K ﹤0.01% 1638
2022
Q2
Sell
-11,983
Closed -$95K 2185
2022
Q1
$95K Buy
+11,983
New +$103K ﹤0.01% 2142
2019
Q1
Sell
-16,639
Closed -$340K 2167
2018
Q4
$340K Sell
16,639
-46,839
-74% -$1.47M ﹤0.01% 1925
2018
Q3
$2.34M Sell
63,478
-5,904
-9% -$258K ﹤0.01% 1341
2018
Q2
$3.49M Buy
69,382
+33,494
+93% +$1.48M ﹤0.01% 1171
2018
Q1
$1.31M Sell
35,888
-3,749
-9% -$115K ﹤0.01% 1558
2017
Q4
$1.12M Buy
39,637
+906
+2% +$21.4K ﹤0.01% 1636
2017
Q3
$749K Buy
38,731
+12,580
+48% +$211K ﹤0.01% 1775
2017
Q2
$438K Buy
26,151
+6,151
+31% +$82.9K ﹤0.01% 1941
2017
Q1
$209K Hold
20,000
﹤0.01% 2106
2016
Q4
$180K Buy
+20,000
New +$172K ﹤0.01% 2163

Other funds holding AXGN

Cliff Asness's AXGN Position: Q2 2026 in Review

Cliff Asness increased its Axogen (AXGN) stake by 86% in Q2 2026, buying an estimated $395K and bringing the position to 21,217 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Cliff Asness first reported a position in AXGN in Q4 2016 and has held it in 19 quarters since. The position peaked at $3.49M in Q2 2018. 251 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Cliff Asness held 21,217 shares of Axogen worth $980K as of Q2 2026.
  • Cliff Asness bought 9,795 Axogen shares in Q2 2026, an estimated $395K.
  • Axogen made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3012 holding.
  • Cliff Asness first reported a position in Axogen in Q4 2016 and has held it in 19 quarters since.
  • Cliff Asness's Axogen position peaked at $3.49M in Q2 2018.
  • 251 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.